Selling And Administration Expenses Изменить Дата
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.76B 424M 2023-12
Baxter International USD 832M 47M 2023-12
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Biogen USD 608.5M 179.7M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cara Therapeutics USD 6.72M 790K 2023-09
Cipla INR 10.91B 245.2M 2023-09
Dr.Reddys Laboratories INR 28.86B 1.29B 2023-09
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Exelixis USD 138.14M 3.58M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Ironwood Pharmaceuticals USD 38.67M 2.62M 2023-12
Merck USD 2.75B 272M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Takeda JPY 252.95B 4.84B 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Xencor USD 15.48M 2.98M 2023-12



Nektar Therapeutics Коммерческие И Административные Расходы - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.